✦ LIBER ✦

Trk kinase inhibitors as new treatments for cancer and pain

✍ Scribed by Wang, Tao; Yu, Dingwei; Lamb, Michelle L

Book ID: 121456873
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 663 KB
Volume: 19
Category: Article
ISSN: 1354-3776
DOI: 10.1517/13543770902721261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK Kinase Inhibitors as Possible Treatm

JAK Kinase Inhibitors as Possible Treatment for Myeloproliferative Disorders and Cancer

✍ Abdel-Magid, Ahmed F. 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 184 KB

Tyrosine kinase inhibitors and gemcitabi

Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer?

✍ Axel Kleespies; Karl-Walter Jauch; Christiane J. Bruns 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Issues and progress with protein kinase

Issues and progress with protein kinase inhibitors for cancer treatment

✍ Dancey, Janet; Sausville, Edward A. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 618 KB

Cyclin-dependent kinases as new targets

Cyclin-dependent kinases as new targets for the prevention and treatment of cancer

✍ Senderowicz, Adrian M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Allosteric and ATP-competitive kinase in

Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment

✍ Carlos García-Echeverría 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Glycogen synthase kinase 3 (GSK-3) inhib

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

✍ Ana Martinez; Ana Castro; Isabel Dorronsoro; Mercedes Alonso 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Glycogen synthase kinase 3 (GSK-3) was initially described as a key enzyme involved in glycogen metabolism, but is now known to regulate a diverse array of cell functions. Two forms of the enzyme, GSK-3alpha and GSK-3beta, have been previously identified. Small molecules inhibitors of GSK-3 may, the